- Home
- MESA vs FGEN Comparison
MESA vs FGEN Comparison
Compare MESA & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- FGEN
- Stock Information
- Founded
- MESA 1982
- FGEN 1993
- Country
- MESA United States
- FGEN United States
- Employees
- MESA N/A
- FGEN N/A
- Industry
- MESA Air Freight/Delivery Services
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- MESA Consumer Discretionary
- FGEN Health Care
- Exchange
- MESA Nasdaq
- FGEN Nasdaq
- Market Cap
- MESA 29.1M
- FGEN 33.5M
- IPO Year
- MESA 2018
- FGEN 2014
- Fundamental
- Price
- MESA $1.17
- FGEN $0.31
- Analyst Decision
- MESA
- FGEN Strong Buy
- Analyst Count
- MESA 0
- FGEN 1
- Target Price
- MESA N/A
- FGEN $10.00
- AVG Volume (30 Days)
- MESA 3.2M
- FGEN 899.4K
- Earning Date
- MESA 06-17-2025
- FGEN 05-05-2025
- Dividend Yield
- MESA N/A
- FGEN N/A
- EPS Growth
- MESA N/A
- FGEN N/A
- EPS
- MESA N/A
- FGEN N/A
- Revenue
- MESA $475,518,000.00
- FGEN $29,621,000.00
- Revenue This Year
- MESA $15.09
- FGEN $232.81
- Revenue Next Year
- MESA $16.19
- FGEN $9.16
- P/E Ratio
- MESA N/A
- FGEN N/A
- Revenue Growth
- MESA N/A
- FGEN N/A
- 52 Week Low
- MESA $0.68
- FGEN $0.18
- 52 Week High
- MESA $1.89
- FGEN $1.74
- Technical
- Relative Strength Index (RSI)
- MESA 63.25
- FGEN 46.92
- Support Level
- MESA $1.05
- FGEN $0.27
- Resistance Level
- MESA $1.13
- FGEN $0.31
- Average True Range (ATR)
- MESA 0.10
- FGEN 0.03
- MACD
- MESA 0.03
- FGEN 0.01
- Stochastic Oscillator
- MESA 89.09
- FGEN 81.38
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.